AzTrials
AzTrials

Type 2 DiabetesNCT07057518

The Effect of Emotional Freedom Technique on Psychological Health and Well-being in People With Type 2 Diabetes.

A study testing emotional freedom technique in people with Type 2 Diabetes, run by Uşak University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Type 2 diabetes is a major meatbolic condition. People living with Type 2 diabetes come across a wide range of health issues, including psychological health. Specifically, diabetes distress are in high levels among them. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Type 2 Diabetes
What is being tested?
emotional freedom technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
6 May 2025to Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • being over 18 years of age,
  • having type 2 diabetes,
  • no psychiatric diagnosis
  • agreeing to participate in the study.

Who cannot join

  • be under 18 years of age,
  • have type 1 diabetes or gestational diabetes,
  • attend any course on coping with diabetes distress and anxiety,
  • have advanced mental health problems.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Aycan ÇELİK ESMER, PhD contact

+922122223085

aycan.esmer@usak.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Istanbul Medeniyet University

    Istanbul

    Berna DINCER, PhD, berna.dincer@medeniyet.edu.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Type 2 diabetes is a major meatbolic condition. People living with Type 2 diabetes come across a wide range of health issues, including psychological health. Specifically, diabetes distress are in high levels among them. Diabetes distress is associated with psychological states such as anxiety, lower levels of self-care, and higher hemoglobin A1c (HbA1c) levels. The Emotional Freedom Technique consists of cognitive and somatic components and is used to heal an individual's negative emotions and manage associated emotional and physical disorders. The basic principle of this technique is to regulate the flow of energy by stimulating the meridian system and to relax the individual while focusing on the emotional reactions that lead to disability. Although the prevalence of psychological problems associated with T2DM and diabetes is increasing, there are not enough studies showing the effect of Emotional Freedom Technique on the psychological well-being of T2DM individuals.

Read the detailed description

Worldwide, 589 million adults (aged 20-79) live with diabetes (IDF, 2025). This number is projected to rise to 853 million by 2050. The latest International Diabetes Federation Diabetes Atlas (2025) reports that 11.1% (or 1 in 9) of the adult population (aged 20-79) live with diabetes, and 4 in 10 are unaware that they have the condition. More than 90% of people with diabetes have type 2 diabetes (T2DM) due to socioeconomic, demographic, environmental, and genetic factors. The main factors contributing to the increase in T2DM are: urbanization, aging population, decreasing physical activity levels, and increasing prevalence of overweight and obesity. T2DM is associated with microvascular and macrovascular complications. T2DM can cause complications due to a two- to four-fold increase in impaired macrovascular circulation and a 10- to 20-fold impairment in microvascular circulation compared to people without diabetes (Gregg, 2019; Mbanya and Sobngwi, 2003). Microvascular complications, namely peripheral neuropathy, retinopathy and nephropathy, result from damage to small blood vessels in the nerves, retina and kidneys, respectively. Macrovascular complications result from damage to large vessels of the heart, brain and legs, causing heart disease (ischemic heart disease), cerebrovascular disease and peripheral vascular disease, respectively (IDF, 2022). Approximately one in three people with diabetes already has microvascular complications when diagnosed with T2DM, and the risk of developing cardiovascular complications is 2-2.5 times higher in people with diabetes compared to people without diabetes (Dal Canto, 2019). In addition, diabetes is a chronic metabolic disease that affects social and mental states, including the psychological well-being of people living with it. For example, a large-scale, cross-sectional study of the Diabetes Attitudes, Wants and Needs (DAWN) study results from around the world showed that 13.8% of 8596 DM patients in 17 countries may have depression, and approximately 50% of patients may have depression (Burns et al. 2013). Diabetes-related distress is a unique emotional problem that is directly related to the burden and anxiety felt by T2DM patients. Diabetes-related distress was found in 60.5% of T2DM patients. With this in mind, it is important to identify and support patients with physical and psychosocial problems early in the course of diabetes, as this may affect their ability to adapt or take adequate responsibility for self-care.

Diabetic distress is associated with psychological states such as anxiety, lower levels of self-care, and higher hemoglobin A1c (HbA1c) levels. Previous studies have shown that depression and anxiety are associated with an increased risk of diabetes complications (Park et al. 2024). The management of T2DM involves complex components aimed at reducing the numerous, wide-ranging complications associated with the condition. In particular, previous studies have found that psychological interventions have a significant effect on diabetic stress and anxiety levels. One of the psychological interventions in T2DM individuals is the Emotional Freedom Technique. This technique is a method derived from energy psychotherapy. The Emotional Freedom Technique consists of cognitive and somatic components and is used to improve the individual's negative emotions and manage associated emotional and physical disorders. The basic principle of this technique is to regulate the energy flow by stimulating the meridian system and to relax the individual while focusing on the emotional reactions that lead to disability. Previous meta-analyses report that this technique is one of the most recognized and widely used types of energy therapy and is effective in the management of stress as well as anxiety, depression, burnout and phobias. A systematic review and meta-analysis of randomized and non-randomized trials of the clinically applied Emotional Freedom Technique for the treatment of depression found that this technique is as effective as cognitive behavioral therapy (Nelms et al. 2016). However, although the prevalence of psychological problems associated with T2DM and diabetes is increasing, there are not enough studies showing the effect of Emotional Freedom Technique on the psychological well-being of T2DM individuals. Therefore, it is thought that this study will lead to future studies.

Conditions
Type 2 Diabetes
Being tested
emotional freedom technique
Keywords
Type 2 diabetes, Emotional Freedom Technique, RCTs
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • emotional freedom techniqueBehavioural

    The EFT application will be implemented by the researcher who has been trained in this subject, in the most quiet and calm environment possible, in a position where the individuals are comfortable. There are basic steps to be followed in EFT application. Thought Field Therapy (TFT), developed by Callahan, based on Craig, uses different click points for specific psychological conditions, while EFT has 12 energy click points in the same specified order to treat every emotional problem, It is called 'Basic Recipe'

Study groups in NCT07057518
Study groupRoleWhat they receive
Emotional freedom technique groupExperimentalThe EFT application will be implemented by the researcher who has been trained in this subject, in the most quiet and calm environment possible, in a position where the individuals are comfortable. There are basic steps to be followed in EFT application. Thought Field Therapy (TFT), developed by Callahan, based on Craig, uses different click points for specific psychological conditions, while EFT has 12 energy click points in the same specified order to treat every emotional problem, It is called 'Basic Recipe'
Receives: Behavioral: emotional freedom technique
Control groupNo interventionNo intervention was made to the people with Type 2 diabetes in the control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. WHO-5

    The WHO-5 scale is used to measure and evaluate an individual's emotion or happiness. The raw score is calculated by summing the five item scores and ranges from 0 to 25, with 0 representing the worst possible quality of life and 25 representing the best possible quality of life.

    Measured: Two months

  2. Diabetes Stress Scale

    The scale is used to assess diabetes distress. The diabetes stress scale demonstrates good internal consistency, indicating that the component questions measure a similar construct. Higher scores-that is, scores above 3 on the diabetes stress scale-indicate greater levels of diabetes distress and have been found to be significantly associated with suboptimal lifestyle and higher HbA1c.

    Measured: Two months

  3. General Anxiety Scale - 7

    The scale was used to measure the severity of anxiety symptoms. Total scores range from 0 to 21, with scores of 5, 10, and 15 representing mild, moderate, and severe anxiety thresholds, respectively, and were used to create a four-category ordinal variable. A cut-off point of 10 was used to distinguish between anxiety and no anxiety.

    Measured: Two months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2025
  2. Study start6 May 2025
  3. Primary completionJul 2025 (estimated)
  4. Study completionJul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
People with Type 2 diabetes who meet the inclusion criteria for the research will use the Random.org website to allocate participants to the Emotional Freedom Technique and Control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07057518
Sponsor's protocol ID
642-642-11
Status last verified
May 2025
First submitted
7 Jul 2025
Last updated
10 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing emotional freedom technique in people with Type 2 Diabetes, run by Uşak University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aycan ÇELİK ESMER, PhD (+922122223085, aycan.esmer@usak.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

WHO-5 (time frame: Two months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in